AstraZeneca Pharma India Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AstraZeneca Pharma India Limited's shareholders have approved the relocation of the company's registered office from the State of Karnataka to the State of Maharashtra. The approval was granted via a special resolution passed through postal ballot (remote e-voting), with results declared on May 11, 2026. The amendment to the 2nd Clause of the Memorandum of Association is subject to receipt of requisite regulatory approvals under the Companies Act, 2013.
This administrative relocation of registered office may have tax, regulatory, and operational implications depending on the jurisdictions involved. No immediate impact on business operations expected since the change is still pending regulatory approvals.